Home › Funds › Alkeon Capital Management › ANRO
Alkeon Capital Management position in ANRO
ALTO NEUROSCIENCE INC · Health Care
Latest position (Q2 2026)102.10K sh
Reported value held$2.69M
Portfolio Weight0.00%
First reportedQ2 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 934.90K | $9.99M | New |
| Q3 2024 | 934.90K | $10.70M | Hold |
| Q4 2024 | 477.10K | $2.02M | Reduce |
| Q1 2025 | 477.10K | $1.03M | Hold |
| Q2 2025 | 477.10K | $1.05M | Hold |
| Q3 2025 | 477.10K | $1.92M | Hold |
| Q4 2025 | 477.10K | $8.49M | Hold |
| Q1 2026 | 227.10K | $5.11M | Reduce |
| Q2 2026 | 102.10K | $2.69M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ANRO
- BlackRock Inc 2.12M sh · $55.97M · Q2 2026
- Franklin Resources 1.01M sh · $26.74M · Q2 2026
- Vanguard Group 1.37M sh · $24.31M · Q4 2025
- Geode Capital Management 678.20K sh · $17.90M · Q2 2026
- Northern Trust Corp 632.70K sh · $16.70M · Q2 2026
- Millennium Management 558.32K sh · $14.73M · Q2 2026
- Point72 Asset Management 502.95K sh · $13.27M · Q2 2026
- Goldman Sachs Group 236.83K sh · $6.25M · Q2 2026
- Marshall Wace 225.50K sh · $5.95M · Q2 2026
- Two Sigma Investments 147.30K sh · $3.89M · Q2 2026
- Charles Schwab Investment Management 80.58K sh · $2.13M · Q2 2026